Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Total Voting Rights

27 Dec 2006 07:01

ReNeuron Group plc27 December 2006 27 December 2006 (ReNeuron Group plc "The Company") Total Voting Rights For the purposes of the transitional provisions of the Financial ServicesAuthority's Disclosure and Transparency Rules, the Company's total issued sharecapital at the date of this notice is £1,185,241. The Company's issued share capital consists of 118,524,100 ordinary shares of 1peach, with one voting right per share. There are no shares held in treasury. The total number of voting rights in the Company is therefore 118,524,100. The above figure of 118,524,100 may be used by shareholders as the denominatorfor the calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, the Company, under theDisclosure and Transparency Rules. For further information contact:ReNeuron Group plcMichael Hunt, CEO Tel: 44 (0)1483 302 560 Financial DynamicsDavid Yates Tel: 44 (0)20 7831 3113Nicola Daley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jun 20144:40 pmRNSSecond Price Monitoring Extn
24th Jun 20144:35 pmRNSPrice Monitoring Extension
20th Jun 20143:24 pmRNSNotification of Major Interest in Shares
20th Jun 20143:18 pmRNSNotification of Major Interest in Shares
18th Jun 20147:00 amRNSPreliminary Results
3rd Jun 20147:00 amRNSNotification of Preliminary Results
14th May 201412:00 pmRNSNotification of Major Interest in Shares
8th May 20149:00 amRNSNotification of Major Interest in Shares
7th May 20147:00 amRNSFurther Data from PISCES Trial
23rd Apr 20147:00 amRNSCorporate update
15th Apr 20147:00 amRNSSigns Lease to New Facility in Wales
27th Mar 20147:00 amRNSUK Clinical Trial Approvals
17th Mar 201411:00 amRNSBlock Listing Six Monthly Review
14th Mar 201412:45 pmRNSSupport for Early Access to Medicines Scheme
21st Jan 20147:00 amRNSPublication of Positive Pre-Clinical Data
27th Dec 20134:40 pmRNSSecond Price Monitoring Extn
27th Dec 20134:35 pmRNSPrice Monitoring Extension
10th Dec 20134:40 pmRNSSecond Price Monitoring Extn
10th Dec 20134:35 pmRNSPrice Monitoring Extension
2nd Dec 20137:00 amRNSInterim Results
19th Nov 20137:00 amRNSNotification of Interim Results
17th Sep 20137:00 amRNSDirectors' Interest in Shares and Share Options
13th Sep 201311:04 amRNSResults of 2013 Annual General Meeting
13th Sep 20137:00 amRNSAGM Trading Update
29th Aug 20137:00 amRNSOrphan Drug Designation
21st Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
21st Aug 20137:00 amRNSDirector/PDMR Shareholding
15th Aug 20137:00 amRNSPosting of Annual Report & Notice of AGM
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
7th Aug 201311:03 amRNSResult of General Meeting
1st Aug 20137:00 amRNSWins £1.5 Million Grant
22nd Jul 20137:01 amRNS£33 Million Financing Package
22nd Jul 20137:00 amRNSPreliminary Results
18th Jul 20134:40 pmRNSSecond Price Monitoring Extn
18th Jul 20134:35 pmRNSPrice Monitoring Extension
1st Jul 20137:00 amRNSNotification of Preliminary Results
1st Jul 20137:00 amRNSWelcomes House of Lords Report
5th Jun 20134:40 pmRNSSecond Price Monitoring Extn
5th Jun 20134:35 pmRNSPrice Monitoring Extension
28th May 20137:00 amRNSStroke Trial Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.